Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus

Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus

US Patent 7294687 · Granted Nov 13, 2007

Estimated economic value: $36,861,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Low frequency glatiramer acetate therapy2016
Low frequency glatiramer acetate therapy2015
Low frequency glatiramer acetate therapy2015
Methods for treating multiple sclerosis using antisense oligonucleotides2014
Methods for treating multiple sclerosis using antisense oligonucleotides2013
Low frequency glatiramer acetate therapy2013
Process for the measurement of the potency of glatiramer acetate2013
Stable laquinimod preparations2013
Low frequency glatiramer acetate therapy2012
Formulations of ladostigil tartrate2011
Stable laquinimod preparations2011
Process for the measurement of the potency of glatiramer acetate2011